Mass drug administration for malaria: A means to what end?

Journal of Infectious Diseases

Volumn 214, Issue 12, 2016, Pages 1790-1792

  Chen, Ingrid ^a   Gosling, Roly ^a   Drakeley, Chris ^b   Bousema, Teun ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dihydroartemisinin piperaquine; Elimination; Falciparum; Zambia

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; QUINOLINE DERIVATIVE;

ADMINISTRATION OF DRUGS, FOOD AND CHEMICALS; ANOPHELES FUNESTUS; ANTIMALARIAL DRUG RESISTANCE; EDITORIAL; ENDEMIC DISEASE; HUMAN; INFECTION PREVENTION; MALARIA; MASS DRUG ADMINISTRATION; NONHUMAN; PARASITE PREVALENCE; PARASITE TRANSMISSION; PARASITE VECTOR; RAPID TEST; VECTOR CONTROL; COMBINATION DRUG THERAPY; MALARIA FALCIPARUM;

ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; MASS DRUG ADMINISTRATION; QUINOLINES;

EID: 85016005510     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw484     Document Type: Editorial

References (22)

1. von Seidlein L, Dondorp A. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther 2015; 13:715-30.
2. Cook J, XuW, Msellem M, et al. Mass screening and treatment on the basis of results of a plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in zanzibar. J Infect Dis 2015; 211:1476-83.
3. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev 2013; 12: CD008846.
4. Newby G, Hwang J, Koita K, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg 2015; 93:125-34.
5. Gosling RD, Okell L, Mosha J, Chandramohan D. The role of antimalarial treatment in the elimination of malaria. Clin Microbiol Infect 2011; 17: 1617-23.
6. Ceesay SJ, Casals-Pascual C, Erskine J, et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 2008; 372:1545-54.
7. Derua YA, Alifrangis M, Hosea KM, et al. Change in composition of the Anopheles gambiae complex and its possible implications for the transmission of malaria and lymphatic filariasis in north-eastern Tanzania. Malaria J 2012; 11:188.
8. Smith DL, Perkins TA, Reiner RC Jr, et al. Recasting the theory of mosquito-borne pathogen transmission dynamics and control. Trans R Soc Trop Med Hyg 2014; 108:185-97.
9. Wesolowski A, Eagle N, Tatem AJ, et al. Quantifying the impact of human mobility on malaria. Science 2012; 338:267-70.
10. PMI. Africa IRS (AIRS) Project Indoor Residual Spraying (IRS) Task Order 6. Zambia end of spray report. Bethesda, MD: Abt Associates, 2016.
11. Kanyangarara M, Mamini E, Mharakurwa S, et al. Reduction in malaria incidence following indoor residual spraying with actellic 300 CS in a setting with pyrethroid resistance: Mutasa District, Zimbabwe. PLoS One 2016; 11:e0151971.
12. World Health Organization. World malaria report. http://www. who. int/malaria/publications/worldmalaria-report-2015/wmr2015-without-profiles. pdf. Accessed 21 September 2016.
13. World Health Organization. Overview of malaria elimination. http://www. who. int/malaria/areas/ elimination/overview/en/. Accessed 21 September 2016.
14. Stresman GH, Baidjoe AY, Stevenson J, et al. Focal screening to identify the subpatent parasite reservoir in an area of low and heterogeneous transmission in the Kenya highlands. J Infect Dis 2015; 212: 1768-77.
15. Ouedraogo AL, Goncalves BP, Gneme A, et al. Dynamics of the human infectious reservoir for malaria determined by mosquito feeding assays and ultrasensitive malaria diagnosis in burkina faso. J Infect Dis 2016; 213:90-9.
16. Goncalves BP, Drakeley C, Bousema T. Infectivity of microscopic and submicroscopic malaria parasite infections in areas of low malaria endemicity. J Infect Dis 2016; 213:1516-7.
17. Lin JT, Ubalee R, Lon C, et al. Microscopic plasmodium falciparum gametocytemia and infectivity to mosquitoes in Cambodia. J Infect Dis 2016; 213: 1491-4.
18. Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol 2014; 12:833-40.
19. Okell LC, Griffin JT, Kleinschmidt I, et al. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One 2011; 6:e20179.
20. Slater HC, Walker PG, Bousema T, Okell LC, Ghani AC. The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study. J Infect Dis 2014; 210:1972-80.
21. Dapeng L, Leyuan S, Xili L, Xiance Y. A successful control programme for falciparum malaria in Xinyang, China. Trans R Soc Trop Med Hyg 1996; 90:100-2.
22. Deng C, Wang Q, Zheng S, et al. Mass drug administration of artemisinin-piperaquine on high malaria epidemic area. Trop Med Health 2014; 42:33-41.